CEO, Axonics
WHY: Runs medical device maker that went public in 2018, has flirted with $1B market valuation for much of 2019.
RECENT: Axonics adding local space— 67K SF for their Irvine HQ—and employee headcount as products used to treat overactive bladder and other urinary and bowel conditions get FDA approvals and firm ramps up sales.
NOTABLE: Has served as chairman for BioLife Solutions for 13 years, Syncroness for 11 years, Lombard Medical for 5 years, and DYSIS Medical for 2 years. Has Bachelor of Science in business management from Binghamton University.
FUN FACTS: Favorite book, “Brave New World”; film, “Pulp Fiction.”
